RX-5902-P1-01: A Multi-Center, Dose Finding, Open Label, Phase 1 Study of RX-5902 in Subjects With Advanced or Metastatic Solid Tumors (Stage 1 and Stage 2 of Phase 2)

February 24, 2019
Solid Tumors, Cancer - Ovarian
Principal Investigator: Ding Wang, MD
Cancer, Solid Tumors, Phase 1, Phase I, Phase 2, Phase II, Advanced, Metastatic